Cargando…

Immunohistochemical markers of the hypoxic response can identify malignancy in phaeochromocytomas and paragangliomas and optimize the detection of tumours with VHL germline mutations

BACKGROUND: There are no reliable markers of malignancy in phaeochromocytomas (PCC) and paragangliomas (PGL). We investigated the relevance of the mammalian target of rapamycin (mTOR)/AKT and hypoxic pathways as novel immunohistochemical markers of malignancy. METHODS: Tissue microarray blocks were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinato, D J, Ramachandran, R, Toussi, S T K, Vergine, M, Ngo, N, Sharma, R, Lloyd, T, Meeran, K, Palazzo, F, Martin, N, Khoo, B, Dina, R, Tan, T M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566818/ https://www.ncbi.nlm.nih.gov/pubmed/23257898 http://dx.doi.org/10.1038/bjc.2012.538

Ejemplares similares

An expression signature of the angiogenic response in gastrointestinal neuroendocrine tumours: correlation with tumour phenotype and survival outcomes
por: Pinato, D J, et al.
Publicado: (2014)

Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior
por: Pinato, David J., et al.
Publicado: (2017)

Predictors of outcome in phaeochromocytomas and paragangliomas
por: Nicolas, Marlo, et al.
Publicado: (2017)

Precision Medicine in Phaeochromocytoma and Paraganglioma
por: Winzeler, Bettina, et al.
Publicado: (2021)

The clinical genetics of phaeochromocytoma and paraganglioma
por: Kavinga Gunawardane, P. T., et al.
Publicado: (2017)

Phaeochromocytoma and Paraganglioma Excision Involving the Great Vessels
por: Srirangalingam, U., et al.
Publicado: (2017)

The immune cell infiltrate in the tumour microenvironment of phaeochromocytomas and paragangliomas
por: Tufton, N, et al.
Publicado: (2022)

Molecular and immunohistochemical analysis of P53 in phaeochromocytoma.
por: Dahia, P. L., et al.
Publicado: (1995)

Recurrence of Phaeochromocytoma and Abdominal Paraganglioma After Initial Surgical Intervention
por: Johnston, Philip C, et al.
Publicado: (2015)

A Laboratory Medicine Perspective on the Investigation of Phaeochromocytoma and Paraganglioma
por: Boot, Christopher S.
Publicado: (2023)

Phaeochromocytomas/paragangliomas and adverse clinical outcomes in patients with Neurofibromatosis type 1
por: Al-Sharefi, A, et al.
Publicado: (2018)

Identification of Novel Mutations and Expressions of EPAS1 in Phaeochromocytomas and Paragangliomas
por: Islam, Farhadul, et al.
Publicado: (2020)

Clinical Presentation and Outcomes of Phaeochromocytomas/Paragangliomas in Neurofibromatosis Type 1
por: Al-Sharefi, Ahmed, et al.
Publicado: (2019)

Glucose Intolerance on Phaeochromocytoma and Paraganglioma—The Current Understanding and Clinical Perspectives
por: Abe, Ichiro, et al.
Publicado: (2020)

MON-220 Real World Performance of Urinary and Plasma Metanephrine Assays in Diagnosing Phaeochromocytoma/Paraganglioma
por: Deyab, Eithar, et al.
Publicado: (2020)

Profiling of Somatic Mutations in Phaeochromocytoma and Paraganglioma by Targeted Next Generation Sequencing Analysis
por: Luchetti, Andrea, et al.
Publicado: (2015)

Investigating the role of somatic sequencing platforms for phaeochromocytoma and paraganglioma in a large UK cohort
por: Winzeler, Bettina, et al.
Publicado: (2021)

PIAS4 is an activator of hypoxia signalling via VHL suppression during growth of pancreatic cancer cells
por: Chien, W, et al.
Publicado: (2013)

Phaeochromocytoma Mimicking Scleroderma
por: Khoo, Joan Joo-Ching, et al.
Publicado: (2011)

Genetic testing and immunohistochemistry for SDHB in phaeochromocytoma-paraganglioma syndromes: the South Australian experience
por: Poplawski, NK, et al.
Publicado: (2012)

Concurrent Urinary Bladder Paraganglioma and Adrenal Phaeochromocytoma With Succinate Dehydrogenase-B Mutation
por: Hafiz, Bayan, et al.
Publicado: (2021)

The VHL gene is epigenetically inactivated in pheochromocytomas and abdominal paragangliomas
por: Andreasson, Adam, et al.
Publicado: (2013)

The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma
por: Peng, Song, et al.
Publicado: (2020)

Immunohistochemical estimation of cell cycle phase in laryngeal neoplasia
por: Chatrath, P, et al.
Publicado: (2006)

Clinical Practice Guidance: Surveillance for phaeochromocytoma and paraganglioma in paediatric succinate dehydrogenase gene mutation carriers
por: Wong, Mei Yin, et al.
Publicado: (2019)

Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma
por: Patard, J-J, et al.
Publicado: (2009)

MON-194 Phaeochromocytoma-Paraganglioma (PPGL): Post-Operative Hypotension Is a Vanishing Phenomenon
por: Osher, Esther, et al.
Publicado: (2020)

The use of temozolomide in paediatric metastatic phaeochromocytoma/paraganglioma: A case report and literature review
por: Urquhart, Calum, et al.
Publicado: (2022)

Studies in Phaeochromocytoma: III. The Excretion of Noradrenaline in the Urine of Cases of Hypertension and Its Value in the Diagnosis of Phaeochromocytoma
por: West, G. B., et al.
Publicado: (1955)

The von Hippel–Lindau tumour suppressor gene: uncovering the expression of the pVHL172 isoform
por: Chesnel, F, et al.
Publicado: (2015)

Mediastinal paragangliomas related to SDHx gene mutations
por: Michałowska, Ilona, et al.
Publicado: (2016)

Germline mutations in the new E1’ cryptic exon of the VHL gene in patients with tumours of von Hippel-Lindau disease spectrum or with paraganglioma
por: Buffet, Alexandre, et al.
Publicado: (2020)

Evaluation of models to predict BRCA germline mutations
por: Kang, H H, et al.
Publicado: (2006)

TRIM59, a novel multiple cancer biomarker for immunohistochemical detection of tumorigenesis
por: Khatamianfar, Vida, et al.
Publicado: (2012)

Lack of EGF receptor contributes to drug sensitivity of human germline cells
por: Park, S-J, et al.
Publicado: (2005)

Immunohistochemical categorisation of ductal carcinoma in situ of the breast
por: Meijnen, P, et al.
Publicado: (2008)

Phaeochromocytoma Crisis: Two Cases of Undiagnosed Phaeochromocytoma Presenting after Elective Nonrelated Surgical Procedures
por: Johnston, P. C., et al.
Publicado: (2013)

Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer
por: Smith, R A, et al.
Publicado: (2011)

Investigation of pathogenic mechanisms in multiple colorectal adenoma patients without germline APC or MYH/MUTYH mutations
por: Thirlwell, C, et al.
Publicado: (2007)

Catecholamine induced cardiomyopathy in phaeochromocytoma
por: Panda, Prashant K., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_srr3vhpfgt6ntscasjqh1pk355